Literature DB >> 1705168

Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters.

W Parzefall1, E Erber, R Sedivy, R Schulte-Hermann.   

Abstract

Parenchymal liver cells were isolated from human liver pieces of surgical waste as well as from rat livers. DNA synthetic activity was measured after different times in primary culture by [3H]thymidine incorporation and autoradiography. Labeling of control cultures of human hepatocytes at densities between 8,000 and 15,000 cells/cm2 was very low (0.4 to 1.3%). Human recombinant epidermal growth factor increased labeling 2- to 4-fold (P less than 0.01). Treatment with known inducers of liver growth in rats, namely, cyproterone acetate, alpha-hexachlorocyclohexane, nafenopin, phenobarbital, and rifampicin did not increase the number of labeled human liver cells. In some of the experiments, a 24-h exposure to the chemicals of rat or human hepatocytes was followed by a 24-h treatment with epidermal growth factor (EGF). In rat hepatocytes, incorporation rates were significantly increased. Cyproterone acetate and EGF acted in an additive manner, alpha-hexachlorocyclohexane and EGF were clearly overadditive, and phenobarbital had little effect. In human hepatocytes, little alteration in labeling indices was found; in some cases labeling was, rather, found to be lower than in cultures treated with EGF alone. These results show that human hepatocytes cultured in vitro are sensitive to stimulation of DNA synthesis by EGF; they differ from rat hepatocytes in their response to some drugs which show liver growth-promoting activity in rodents.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1705168

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Epidermal growth factor, DNA synthesis and human hepatocytes.

Authors:  A P Li; C A Myers; M A Roque; D L Kaminski
Journal:  In Vitro Cell Dev Biol       Date:  1991-11

2.  Candidate genes responsible for early key events of phenobarbital-promoted mouse hepatocellular tumorigenesis based on differentiation of regulating genes between wild type mice and humanized chimeric mice.

Authors:  Ayako Ohara; Yasuhiko Takahashi; Miwa Kondo; Yu Okuda; Shuji Takeda; Masahiko Kushida; Kentaro Kobayashi; Kayo Sumida; Tomoya Yamada
Journal:  Toxicol Res (Camb)       Date:  2017-08-24       Impact factor: 3.524

Review 3.  Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators.

Authors:  Brian G Lake
Journal:  Toxicol Res (Camb)       Date:  2018-03-12       Impact factor: 3.524

Review 4.  Cyproterone acetate: is it hepato- or genotoxic?

Authors:  T Rabe; K Feldmann; L Heinemann; B Runnebaum
Journal:  Drug Saf       Date:  1996-01       Impact factor: 5.606

Review 5.  Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator.

Authors:  Clifford R Elcombe; Richard C Peffer; Douglas C Wolf; Jason Bailey; Remi Bars; David Bell; Russell C Cattley; Stephen S Ferguson; David Geter; Amber Goetz; Jay I Goodman; Susan Hester; Abigail Jacobs; Curtis J Omiecinski; Rita Schoeny; Wen Xie; Brian G Lake
Journal:  Crit Rev Toxicol       Date:  2013-11-04       Impact factor: 5.635

6.  Mesenchyme-derived factors enhance preneoplastic growth by non-genotoxic carcinogens in rat liver.

Authors:  Marzieh Nejabat; Teresa Riegler; Tabea Reitinger; Sandra Subosits; Michael Römer; Johannes Eichner; Martin Bilban; Andreas Zell; Wolfgang W Huber; Rolf Schulte-Hermann; Bettina Grasl-Kraupp
Journal:  Arch Toxicol       Date:  2017-12-21       Impact factor: 5.153

7.  Human constitutive androstane receptor represses liver cancer development and hepatoma cell proliferation by inhibiting erythropoietin signaling.

Authors:  Zhihui Li; So Mee Kwon; Daochuan Li; Linhao Li; Xiwei Peng; Junran Zhang; Tatsuya Sueyoshi; Jean-Pierre Raufman; Masahiko Negishi; Xin Wei Wang; Hongbing Wang
Journal:  J Biol Chem       Date:  2022-03-30       Impact factor: 5.486

8.  Proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver.

Authors:  Heike Sprenger; Josef Daniel Rasinger; Helen Hammer; Wael Naboulsi; Elke Zabinsky; Hannes Planatscher; Michael Schwarz; Oliver Poetz; Albert Braeuning
Journal:  Arch Toxicol       Date:  2022-07-26       Impact factor: 6.168

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.